These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38397958)

  • 21. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.
    Borghero G; Pugliatti M; Marrosu F; Marrosu MG; Murru MR; Floris G; Cannas A; Parish LD; Cau TB; Loi D; Ticca A; Traccis S; Manera U; Canosa A; Moglia C; Calvo A; Barberis M; Brunetti M; Renton AE; Nalls MA; Traynor BJ; Restagno G; Chiò A;
    Neurobiol Aging; 2015 Oct; 36(10):2906.e1-5. PubMed ID: 26208502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.
    Kim YE; Oh KW; Noh MY; Park J; Kim HJ; Park JE; Ki CS; Kim SH
    Neurobiol Aging; 2018 Jul; 67():201.e5-201.e8. PubMed ID: 29665996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.
    Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM
    Ann Neurol; 2016 Feb; 79(2):295-305. PubMed ID: 26599997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous ALS and SCA2 associated with an intermediate-length
    Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the phenotype of Italian patients with ALS with intermediate
    Chio A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor B; Corrado L; D'Alfonso S; Mazzini L; Calvo A
    J Neurol Neurosurg Psychiatry; 2022 Aug; 93(11):1216-20. PubMed ID: 36008116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.
    van Blitterswijk M; Mullen B; Heckman MG; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
    Neurobiol Aging; 2014 Oct; 35(10):2421.e13-7. PubMed ID: 24866401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72.
    Snowden JS; Harris J; Richardson A; Rollinson S; Thompson JC; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):172-6. PubMed ID: 23421625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis.
    Chiò A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor BJ; Corrado L; D'Alfonso S; Mazzini L; Calvo A
    Neurology; 2023 Jul; 101(1):e83-e93. PubMed ID: 37202167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeats expansions in
    Nel M; Mavundla T; Gultig K; Botha G; Mulder N; Benatar M; Wuu J; Cooley A; Myers J; Rampersaud E; Wu G; Heckmann JM
    IBRO Neurosci Rep; 2021 Jun; 10():130-135. PubMed ID: 34179866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis.
    Lu HP; Gan SR; Chen S; Li HF; Liu ZJ; Ni W; Wang N; Wu ZY
    Neurobiol Aging; 2015 Mar; 36(3):1603.e11-4. PubMed ID: 25457026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.
    Naruse H; Matsukawa T; Ishiura H; Mitsui J; Takahashi Y; Takano H; Goto J; Toda T; Tsuji S
    Neurogenetics; 2019 May; 20(2):65-71. PubMed ID: 30847648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Dewan R; Chia R; Ding J; Hickman RA; Stein TD; Abramzon Y; Ahmed S; Sabir MS; Portley MK; Tucci A; Ibáñez K; Shankaracharya FNU; Keagle P; Rossi G; Caroppo P; Tagliavini F; Waldo ML; Johansson PM; Nilsson CF; ; ; ; ; ; ; ; ; Rowe JB; Benussi L; Binetti G; Ghidoni R; Jabbari E; Viollet C; Glass JD; Singleton AB; Silani V; Ross OA; Ryten M; Torkamani A; Tanaka T; Ferrucci L; Resnick SM; Pickering-Brown S; Brady CB; Kowal N; Hardy JA; Van Deerlin V; Vonsattel JP; Harms MB; Morris HR; Ferrari R; Landers JE; Chiò A; Gibbs JR; Dalgard CL; Scholz SW; Traynor BJ
    Neuron; 2021 Feb; 109(3):448-460.e4. PubMed ID: 33242422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China.
    Jiao B; Tang B; Liu X; Yan X; Zhou L; Yang Y; Wang J; Xia K; Shen L
    Neurobiol Aging; 2014 Apr; 35(4):936.e19-22. PubMed ID: 24269022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72-ALS.
    Laffita-Mesa JM; Nennesmo I; Paucar M; Svenningsson P
    Mov Disord; 2021 Feb; 36(2):508-514. PubMed ID: 33058338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia.
    Yang X; Sun X; Liu Q; Liu L; Li J; Cai Z; Zhang K; Liu S; He D; Shen D; Liu M; Cui L; Zhang X
    Orphanet J Rare Dis; 2022 Nov; 17(1):404. PubMed ID: 36345033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling.
    Gellera C; Ticozzi N; Pensato V; Nanetti L; Castucci A; Castellotti B; Lauria G; Taroni F; Silani V; Mariotti C
    Neurobiol Aging; 2012 Aug; 33(8):1847.e15-21. PubMed ID: 22425256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CAG repeats ≥ 34 in Ataxin-1 gene are associated with amyotrophic lateral sclerosis in a Brazilian cohort.
    Gonçalves JPN; de Andrade HMT; Cintra VP; Bonadia LC; Leoni TB; de Albuquerque M; Martins MP; de Borba FC; Couteiro RED; de Oliveira DS; Claudino R; Gonçalves MVM; Dourado ME; de Souza LC; Teixeira AL; de Godoy Rousseff Prado L; Tumas V; Oliveira ASB; Nucci A; Lopes-Cendes I; Marques W; França MC
    J Neurol Sci; 2020 Jul; 414():116842. PubMed ID: 32339968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 levels in the brain tissue of ALS cases with and without
    Yang Y; Halliday GM; Kiernan MC; Tan RH
    Neurology; 2019 Nov; 93(19):e1748-e1755. PubMed ID: 31619481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2.
    Tazen S; Figueroa K; Kwan JY; Goldman J; Hunt A; Sampson J; Gutmann L; Pulst SM; Mitsumoto H; Kuo SH
    JAMA Neurol; 2013 Oct; 70(10):1302-4. PubMed ID: 23959108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease.
    Lindquist SG; Duno M; Batbayli M; Puschmann A; Braendgaard H; Mardosiene S; Svenstrup K; Pinborg LH; Vestergaard K; Hjermind LE; Stokholm J; Andersen BB; Johannsen P; Nielsen JE
    Clin Genet; 2013 Mar; 83(3):279-83. PubMed ID: 22650353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.